Prehospital Delay
Mostrando 1-9 de 9 artigos, teses e dissertações.
-
1. Factors influencing the decision time for men and women with myocardial infarction to the demand for health services. / Fatores que influenciam o tempo de decisão de homens e mulheres com infarto do miocárdio para a procura de serviço de saúde.
Introdução: O retardo para a decisão da procura de atendimento médico diante do infarto do miocárdio (IAM) é entrave para o recebimento dos benefícios das terapêuticas de reperfusão miocárdica. Objetivo geral: Analisar, para homens (H) e mulheres (M), que sofreram IAM, a influência de fatores socioeconômicos, clínicos, ambientais, cognitivos e e
Publicado em: 2010
-
2. Impact of a public campaign on pre-hospital delay in patients reporting chest pain.
OBJECTIVE: To decrease pre-hospital delay in patients with chest pain. DESIGN: Population based, prospective observational study. SETTING: A province of Switzerland with 380000 inhabitants. SUBJECTS: All 1337 patients who presented with chest pain to the emergency department of the Hôpital Cantonal Universitaire of Geneva during the 12 months of a multimedi
-
3. A model of prehospital death from ventricular fibrillation following myocardial infarction.
Current efforts to reduce prehospital cardiac mortality focus more on deployment of specially equipped ambulances than on reduction of patient or ambulance delays. To evaluate this strategy, we needed to find a method that would isolate the separate effects of patient delay, ambulance delay, and the resuscitative capability of the ambulance. Using published
-
4. Prehospital thrombolysis—calculated health benefit for catchment population of one hospital
The health benefit of thrombolysis in acute myocardial infarction is greatest when patients are treated soon after onset of symptoms. One approach to reducing treatment delay is to give thrombolysis before the patient reaches hospital. When an ambulance trust proposed a prehospital thrombolysis service, local commissioners requested an estimate of its possib
The Royal Society of Medicine.
-
5. The natural history of appendicitis in adults. A prospective study.
OBJECTIVE: The authors relate prehospital delay and in-hospital delay to the incidence of perforation of appendicitis. SUMMARY BACKGROUND DATA: Quality assurance studies use perforation rate as an index of quality of care. This is based on the assumption commonly presented in retrospective reports that in-hospital delay to surgery influences the incidence of
-
6. Patient and doctor delay in acute myocardial infarction: a study in Rotterdam, The Netherlands.
BACKGROUND--Early thrombolytic therapy for patients having a myocardial infarct size and improves survival. AIM--A study was undertaken to examine the components of pre-hospital delay in patients with retrospectively proven myocardial infarction. METHOD--Data were gathered from 300 patients with a documented myocardial infarction admitted to three hospitals
-
7. One-year prospective study of cases of suspected acute myocardial infarction managed by urban and rural general practitioners.
BACKGROUND: The role of the general practitioner in the management of patients with suspected acute myocardial infarction is important and specific. It has been recommended that eligible patients should receive thrombolysis within 90 minutes of alerting medical or ambulance services. The administration of prehospital thrombolysis by general practitioners is
-
8. Audit of thrombolysis initiated in an accident and emergency department.
Early thrombolytic therapy after acute myocardial infarction is important in reducing mortality. To evaluate a system for reducing in-hospital delays to thrombolysis pain to needle and door to needle times to thrombolysis were audited in a major accident and emergency (A and E) department of a district general hospital and its coronary care unit (CCU), situa
-
9. A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.
Within four hours of the onset of acute myocardial infarction 57 consecutive patients were randomised blindly to infusion of 150 mg recombinant tissue plasminogen activator (rt-PA) (group 1) over five hours or placebo (group 2) when they were first seen outside hospital or in the accident and emergency department. When they were admitted to the coronary care